|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.514
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.403
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.384
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.277
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.275
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.254
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.198
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.196
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.190
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.183
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.183
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.178
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.168
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.163
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.155
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.152
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.136
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.136
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.126
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.126
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.124
|
|
|
|
cellular response to muramyl dipeptide
|
GO:0071225 |
3 |
0.119
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.118
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.116
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.115
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.111
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.111
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.106
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.099
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.091
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.091
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.090
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.090
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.088
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.087
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.087
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.085
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.080
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.079
|
|
|
|
regulation of macrophage differentiation
|
GO:0045649 |
9 |
0.079
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.076
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.075
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.075
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.074
|
|
|
|
positive regulation of macrophage differentiation
|
GO:0045651 |
7 |
0.070
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.068
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.068
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.068
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.066
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.066
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.065
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.064
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.064
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
24 |
0.062
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.062
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.062
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.062
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.062
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.061
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.059
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.059
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
61 |
0.057
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.057
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.056
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.056
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.056
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.055
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.055
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.054
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.053
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.053
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.053
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.053
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.052
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.051
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.051
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.050
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
26 |
0.050
|
|
|
|
trail activated apoptotic signaling pathway
|
GO:0036462 |
4 |
0.050
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.049
|
|
|
|
substantia nigra development
|
GO:0021762 |
45 |
0.046
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.046
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.045
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.045
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.044
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.044
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.044
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.043
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.042
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.041
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.041
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.041
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.041
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.041
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.041
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.040
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.040
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.040
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.039
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.038
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.036
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.036
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.036
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.036
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.035
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.035
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.034
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
22 |
0.033
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
51 |
0.033
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.032
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.032
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.031
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.031
|
|
|
|
regulation of neuron death
|
GO:1901214 |
56 |
0.031
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.031
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.031
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.031
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.031
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.030
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
53 |
0.030
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.029
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.029
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.029
|
|
|
|
startle response
|
GO:0001964 |
3 |
0.028
|
|
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.028
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.028
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
42 |
0.027
|
|
|
|
system process
|
GO:0003008 |
349 |
0.026
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.026
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.026
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.026
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.026
|
|
|
|
aortic valve development
|
GO:0003176 |
3 |
0.026
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
14 |
0.026
|
|
|
|
growth
|
GO:0040007 |
202 |
0.026
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
1 |
0.026
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.025
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.025
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.025
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.025
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.025
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.025
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.024
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.024
|
|
|
|
regulation of necroptotic process
|
GO:0060544 |
7 |
0.024
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.024
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.024
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.024
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.024
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.024
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.024
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.024
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
42 |
0.024
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.023
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.023
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
35 |
0.023
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.023
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.023
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
18 |
0.023
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.023
|
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
40 |
0.023
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.023
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.022
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.022
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.022
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.022
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.022
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.022
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.022
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.022
|
|
|
|
peptidyl serine autophosphorylation
|
GO:0036289 |
2 |
0.022
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.022
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.022
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.021
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
15 |
0.021
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.021
|
|
|
|
cellular response to uv
|
GO:0034644 |
32 |
0.021
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.021
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.021
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.021
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.020
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.020
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.020
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.020
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.020
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.020
|
|
|
|
positive regulation of protein polyubiquitination
|
GO:1902916 |
3 |
0.020
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.020
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.020
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.020
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.020
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.020
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.019
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.019
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.019
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
15 |
0.019
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.019
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
2 |
0.019
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.019
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.019
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.019
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.019
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.019
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.019
|
|
|
|
macrophage differentiation
|
GO:0030225 |
11 |
0.019
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.018
|
|
|
|
nucleotide binding oligomerization domain containing 2 signaling pathway
|
GO:0070431 |
4 |
0.018
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.018
|
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.018
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.018
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.018
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.018
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.018
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.018
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.018
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.018
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.018
|
|
|
|
negative regulation of i kappab kinase nf kappab signaling
|
GO:0043124 |
32 |
0.018
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.018
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.018
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.017
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.017
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.017
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.017
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.017
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.017
|
|
|
|
regulation of protein linear polyubiquitination
|
GO:1902528 |
2 |
0.017
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.017
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.017
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.017
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.017
|
|
|
|
mitotic g1 s transition checkpoint
|
GO:0044819 |
17 |
0.017
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.017
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.017
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.017
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
16 |
0.017
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.016
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.016
|
|
|
|
single organism membrane fusion
|
GO:0044801 |
37 |
0.016
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.016
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.016
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.016
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.016
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.016
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.016
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.016
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.016
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
21 |
0.016
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.015
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.015
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.015
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.015
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.015
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
61 |
0.015
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.015
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.015
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.015
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.015
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.015
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.015
|
|
|
|
response to retinoic acid
|
GO:0032526 |
33 |
0.015
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.015
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.015
|
|
|
|
regulation of anion transport
|
GO:0044070 |
25 |
0.015
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.015
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.015
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
37 |
0.014
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
22 |
0.014
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
2 |
0.014
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.014
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.014
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.014
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.014
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.014
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.014
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.014
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.014
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.014
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
19 |
0.014
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.014
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
34 |
0.014
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.014
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.014
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.014
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.014
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.014
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.014
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.014
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.014
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.014
|
|
|
|
positive regulation of protein linear polyubiquitination
|
GO:1902530 |
2 |
0.014
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.014
|
|
|
|
mating
|
GO:0007618 |
1 |
0.013
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.013
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.013
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
74 |
0.013
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.013
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.013
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.013
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.013
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.013
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.013
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.013
|
|
|
|
t cell homeostasis
|
GO:0043029 |
3 |
0.013
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.013
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.013
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
20 |
0.013
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.013
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.013
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.013
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.013
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.013
|
|
|
|
protein polymerization
|
GO:0051258 |
71 |
0.013
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.013
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.013
|
|
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.013
|
|
|
|
cellular response to dexamethasone stimulus
|
GO:0071549 |
1 |
0.013
|
|
|
|
protein k63 linked ubiquitination
|
GO:0070534 |
31 |
0.013
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.013
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.013
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.013
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
45 |
0.013
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
8 |
0.012
|
|
|
|
exocytosis
|
GO:0006887 |
71 |
0.012
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.012
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.012
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.012
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.012
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
31 |
0.012
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.012
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.012
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.012
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.012
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.012
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.012
|
|
|
|
b cell homeostasis
|
GO:0001782 |
1 |
0.012
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.012
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.012
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.012
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.012
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
50 |
0.012
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.012
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.012
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.012
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.012
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.012
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.012
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.012
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.012
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.012
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
4 |
0.011
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.011
|
|
|
|
organelle localization
|
GO:0051640 |
84 |
0.011
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.011
|
|
|
|
sensory perception of sound
|
GO:0007605 |
37 |
0.011
|
|
|
|
midbrain development
|
GO:0030901 |
45 |
0.011
|
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.011
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.011
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.011
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.011
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
51 |
0.011
|
|
|
|
necrotic cell death
|
GO:0070265 |
21 |
0.011
|
|
|
|
negative regulation of myotube differentiation
|
GO:0010832 |
4 |
0.011
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
2 |
0.011
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.011
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.011
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.011
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.011
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.011
|
|
|
|
cochlea development
|
GO:0090102 |
1 |
0.011
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.011
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.011
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.011
|
|
|
|
head development
|
GO:0060322 |
108 |
0.011
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.011
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.011
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.011
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.011
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.011
|
|
|
|
neural nucleus development
|
GO:0048857 |
47 |
0.011
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.011
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.011
|
|
|
|
response to muramyl dipeptide
|
GO:0032495 |
4 |
0.011
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.011
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
40 |
0.010
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.010
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.010
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.010
|
|
|
|
t cell proliferation
|
GO:0042098 |
45 |
0.010
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
25 |
0.010
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
11 |
0.010
|
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.010
|
|
|
|
atp synthesis coupled electron transport
|
GO:0042773 |
4 |
0.010
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.010
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.010
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.010
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.010
|
|